Giessener Elektronische Bibliothek

GEB - Giessener Elektronische Bibliothek

The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth

Jiménez, Adriana P. ; Traum, Annalena ; Boettger, Thomas ; Hackstein, Holger ; Richter, Antje M. ; Dammann, Reinhard H.


Originalveröffentlichung: (2017) Oncotarget 8(51):88437-88452 doi: 10.18632/oncotarget.18177
Zum Volltext im pdf-Format: Dokument 1.pdf (11.893 KB)


Bitte beziehen Sie sich beim Zitieren dieses Dokumentes immer auf folgende
URN: urn:nbn:de:hebis:26-opus-138839
URL: http://geb.uni-giessen.de/geb/volltexte/2018/13883/

Bookmark bei del.icio.us


Freie Schlagwörter (Englisch): RASSF1 , YAP1 , ANKRD1 , tumor suppressor gene , epigenetic
Sammlung: Open Access - Publikationsfonds
Universität Justus-Liebig-Universität Gießen
Institut: Institute for Genetics
Fachgebiet: Biologie
DDC-Sachgruppe: Biowissenschaften, Biologie
Dokumentart: Aufsatz
Sprache: Englisch
Erstellungsjahr: 2017
Publikationsdatum: 27.11.2018
Kurzfassung auf Englisch: The Hippo pathway regulates organ size, growth and comprises several tumor related factors, including the oncoprotein YAP1 and the tumor suppressor RASSF1A. RASSF1A is frequently epigenetically inactivated in cancer. In our study, we analyzed the effect of RASSF1A on the function of YAP1. Expression of YAP1 resulted in the downregulation of several tumor suppressor genes and induction of S-phase. Co-expression with RASSF1A normalized the expression levels of these tumor suppressors and induced a G0-G1 arrest and apoptosis. This effect was associated with the reduction of MDM2 and the increase of p53. These data suggest that the tumor suppressor RASSF1A inhibits the oncogenic potential of YAP1. Additionally, we could show that ANKRD1 is a YAP1 target gene that is induced by RASSF1A. Further analysis revealed that ANKRD1 is epigenetically inactivated in human cancer. ANKRD1 expression induced the expression of TP53 as well as BAX and CDKN1A and reduced colony formation of cancer cells. We found that ANKRD1 interacts with p53 and is involved in the destabilization of MDM2. Additionally, our data indicate that the tumor-suppressive effect of ANKRD1 depends on the presence of p53. These results suggest that ANKRD1 is a tumor-suppressive downstream target of the Hippo pathway that is epigenetically silenced in human cancer.
Lizenz: Lizenz-Logo  Creative Commons - Namensnennung